Predictors of recurrence during years 5-14 in 46,138 women with ER plus breast cancer allocated 5 years only of endocrine therapy (ET).

被引：22

作者：

Pan, Hongchao

Gray, Richard G.

Davies, Christina

Peto, Richard

Bergh, Jonas C. S.

Pritchard, Kathleen I.

Dowsett, Mitch

Hayes, Daniel F.

机构：

[1] Univ Oxford, Oxford, England

[2] Clin Trial Serv Unit CTSU, Oxford, England

[3] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden

[4] SweBCG, Stockholm, Sweden

[5] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

[6] Royal Marsden Hosp, London, England

[7] Inst Canc Res, London, England

[8] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA

来源：

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.505

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

505

引用

页数：2